1. Home
  2. CIVB vs YDES Comparison

CIVB vs YDES Comparison

Compare CIVB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

HOLD

Current Price

$28.21

Market Cap

571.6M

Sector

Finance

ML Signal

HOLD

Logo YD Bio Limited Ordinary Shares

YDES

YD Bio Limited Ordinary Shares

BUY

Current Price

$4.77

Market Cap

476.8M

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
CIVB
YDES
Founded
1884
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
571.6M
476.8M
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
CIVB
YDES
Price
$28.21
$4.77
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $30.92
N/A
AVG Volume (30 Days)
103.5K
★ 361.4K
Earning Date
10-22-2026
08-31-2026
Dividend Yield
★ 2.56%
N/A
EPS Growth
★ 31.34
N/A
EPS
★ 1.41
N/A
Revenue
★ $19,023,000.00
N/A
Revenue This Year
$10.45
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
$19.91
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$21.10
$1.70
52 Week High
$29.97
$17.99

Technical Indicators

Market Signals
Indicator
CIVB
YDES
Relative Strength Index (RSI) 66.50 44.05
Support Level $27.97 $2.33
Resistance Level $29.31 $5.15
Average True Range (ATR) 0.57 0.98
MACD 0.19 -0.31
Stochastic Oscillator 83.07 21.54

Price Performance

Historical Comparison
CIVB
YDES

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: